Menu Back toSession-9-Track-2-Automation-Technologies-in-Medical-Writing

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 9 Track 2: Automation Technologies in Medical Writing

Session Chair(s)

Ruggero  Galici, PhD

Ruggero Galici, PhD

  • Director, Nonclinical and Clinical Pharmacology Writing
  • Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States
Automation technologies, especially when combined with artificial intelligence, are disrupting many sectors including the healthcare. This session will explore challenges and opportunities of automation technologies in medical writing. Few examples of how companies and the FDA are using or plan to use automation technologies to improve efficiencies will be discussed.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify potential automation technologies in medical writing
  • Recognize challenges and opportunities when implementing automation technologies in medical writing


Sian  Ratcliffe, PhD

Automation and AI in Medical Writing: Pie in the Sky or a Paradigm Shift?

Sian Ratcliffe, PhD

  • Vice President, Head of Medical Writing
  • Pfizer Inc, United States
Julia  Forjanic-Klapproth, PhD

AI in the Medical Writing Landscape – Tales from a Pilot Project

Julia Forjanic-Klapproth, PhD

  • Senior Partner/President
  • Trilogy Writing & Consulting, Germany
Eileen E. Navarro Almario, MD, MS, FACP

Digitizing Decision Documentation at the FDA – Are We There Yet?

Eileen E. Navarro Almario, MD, MS, FACP

  • Lead Medical Officer, OCS, OTS, CDER
  • FDA, United States